s1pr

  1. SNT Gatchaman

    A blood-based mRNA signature distinguishes people with Long COVID from recovered individuals, 2024, Missailidis, Annesley+

    A blood-based mRNA signature distinguishes people with Long COVID from recovered individuals Missailidis, Daniel; Ebrahimie, Esmaeil; Mohammadi-Dehcheshmeh, Manijeh; Allan, Claire; Sanislav, Oana; Fisher, Paul Robert; Gras, Stephanie; Annesley, Sarah Jane Long COVID is a debilitating condition...
  2. SNT Gatchaman

    Review The role of Sphingolipids in myelination and myelin stability and their involvement in childhood and adult demyelinating disorders, 2021, Giussani+

    The role of Sphingolipids in myelination and myelin stability and their involvement in childhood and adult demyelinating disorders Paola Giussani; Alessandro Prinetti; Cristina Tringali Multiple sclerosis (MS) represents the most common demyelinating disease affecting the central nervous system...
  3. SNT Gatchaman

    Review Sphingolipids and their metabolism in physiology and disease, 2017, Hannun, Yusuf A. and Obeid, Lina M.

    Sphingolipids and their metabolism in physiology and disease Hannun, Yusuf A.; Obeid, Lina M. Studies of bioactive lipids in general and sphingolipids in particular have intensified over the past several years, revealing an unprecedented and unanticipated complexity of the lipidome and its many...
  4. Mij

    Dysregulations in hemostasis, metabolism, immune response, and angiogenesis in post-acute COVID with and w/o POTS..., 2023, Mahdi et al

    Full Title: Dysregulations in hemostasis, metabolism, immune response, and angiogenesis in post-acute COVID-19 with and without POTS syndrome; a multi-omic profiling study, 2023, Ali Mahdi et al Abstract Post-acute COVID-19 (PACS) are associated with cardiovascular dysfunction, especially...
  5. Andy

    Sphingosine-1-phosphate receptor 1 activation in the central nervous system drives cisplatin-induced cognitive impairment, 2022, Squillace et al

    Cancer-related cognitive impairment (CRCI) is a major neurotoxicity affecting more than 50% of cancer survivors. The underpinning mechanisms are mostly unknown, and there are no FDA-approved interventions. Sphingolipidomic analysis of mouse prefrontal cortex and hippocampus, key sites of...
Back
Top